Published 2 years ago

Biogen agrees to $900 mln drug kickback settlement, U.S. Justice Dept says

Summary by Ground News

US pharmaceutical company Biogen has reached a $900 million settlement with a whistleblower who accused the firm of having paid bribes to doctors to encourage them to prescribe its drugs against multiple sclerosis. The whistleblower behind the report, Michael Bawduniak, will receive about $250 million directly, according to a statement released Monday by the US Justice Department.

0 Articles

All

Left

Center

Right

News18 India

US Pharma Co Biogen Accused of Bribing Doctors for Pushing Drug, Settle for $900mn with Whistleblower

2 years ago·India

Read Full Article

Reuters

Biogen agrees to $900 mln drug kickback settlement, U.S. Justice Dept says

WASHINGTON - The U.S. Justice Department said on Monday that Biogen Inc had agreed to pay $900 million to resolve allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs, leading to the submission of false Medicare and Medicaid claims. (Reporting by Eric Beech and Rami Ayyub; Editing by Chris Reese)

2 years ago·United Kingdom

Read Full Article

Associated Press News

Biogen pays $900M to settle doctor kickback allegations

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple

2 years ago·United States

Read Full Article

abc News

Biogen pays $900M to settle doctor kickback allegations

Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade them to prescribe its multiple sclerosis drugs

2 years ago·United States

Read Full Article

Washington Times

Pharmaceutical company Biogen agrees to pay $900 million to settle kickback claims

Pharmaceutical company Biogen Inc. has agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to recommend its multiple sclerosis drugs, causing false submission claims to Medicare and Medicaid.

2 years ago·United States

Read Full Article

KRDO

Biogen pays $900M to settle doctor kickback allegations

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade them to prescribe its multiple sclerosis drugs. Federal prosecutors in Boston say the agreement announced Monday settles a whistleblower lawsuit brought by a former Biogen employee. Under the settlement, Biogen will pay more than $843 million to the federal …

2 years ago·Colorado Springs, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.